Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 111

    1.

    Variable effects of transgenic c-Maf on autoimmune diabetes.

    Pauza ME, Nguyen A, Wolfe T, Ho IC, Glimcher LH, von Herrath M, Lo D.

    Diabetes. 2001 Jan;50(1):39-46.PMID: 11147792 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool.

    Serreze DV, Johnson EA, Chapman HD, Graser RT, Marron MP, DiLorenzo TP, Silveira P, Yoshimura Y, Nathenson SG, Joyce S.

    Diabetes. 2001 Sep;50(9):1992-2000.PMID: 11522664 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Enhanced T cell responses contribute to the genetic predisposition of CD8-mediated spontaneous autoimmunity.

    Garza KM, McKall-Faienza KJ, Otheki T, Zakarian A, Odermatt B, Ohashi PS.

    Eur J Immunol. 2002 Mar;32(3):885-94.PMID: 11870633 [PubMed - indexed for MEDLINE]Related articles

    4.

    IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation.

    Yang Y, Ochando J, Yopp A, Bromberg JS, Ding Y.

    J Immunol. 2005 Mar 1;174(5):2720-9.PMID: 15728480 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4.

    Ho IC, Hodge MR, Rooney JW, Glimcher LH.

    Cell. 1996 Jun 28;85(7):973-83.PMID: 8674125 [PubMed - indexed for MEDLINE]Related articles

    6.

    Protection from type 1 diabetes in the face of high levels of activated autoaggressive lymphocytes in a viral transgenic mouse model crossed to the SV129 strain.

    von Herrath MG, Wolfe T, Möhrle U, Coon B, Hughes A.

    Diabetes. 2001 Dec;50(12):2700-8.PMID: 11723052 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.

    Wu AY, Schulman SJ, Marconi LA, Reilly CR, Scott B, Lo D.

    Cell Immunol. 1998 Mar 15;184(2):112-20.PMID: 9630837 [PubMed - indexed for MEDLINE]Related articles

    8.
    9.

    CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

    Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA.

    J Immunol. 2005 Aug 1;175(3):1677-85.PMID: 16034108 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.

    Mukherjee R, Wagar D, Stephens TA, Lee-Chan E, Singh B.

    J Immunol. 2005 May 1;174(9):5306-15.PMID: 15843527 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A stage-specific functional role of the leucine zipper transcription factor c-Maf in lung Th2 cell differentiation.

    Hausding M, Ho IC, Lehr HA, Weigmann B, Lux C, Schipp M, Galle PR, Finotto S.

    Eur J Immunol. 2004 Dec;34(12):3401-12.PMID: 15495158 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impaired IL-4 production by CD8+ T cells in NOD mice is related to a defect of c-Maf binding to the IL-4 promoter.

    Chen XP, Falkner DH, Morel PA.

    Eur J Immunol. 2005 May;35(5):1408-17.PMID: 15832295 [PubMed - indexed for MEDLINE]Related articles

    13.

    T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes.

    Pauza ME, Neal H, Hagenbaugh A, Cheroutre H, Lo D.

    Diabetes. 1999 Oct;48(10):1948-53.PMID: 10512358 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

    Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E.

    Biochem Biophys Res Commun. 2003 May 2;304(2):378-84.PMID: 12711326 [PubMed - indexed for MEDLINE]Related articles

    15.

    Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice.

    Kanagawa O, Militech A, Vaupel BA.

    J Immunol. 2002 Jun 15;168(12):6159-64.PMID: 12055228 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rotavirus infection accelerates type 1 diabetes in mice with established insulitis.

    Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS.

    J Virol. 2008 Jul;82(13):6139-49. Epub 2008 Apr 16.PMID: 18417562 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.

    Anastasi E, Campese AF, Bellavia D, Bulotta A, Balestri A, Pascucci M, Checquolo S, Gradini R, Lendahl U, Frati L, Gulino A, Di Mario U, Screpanti I.

    J Immunol. 2003 Nov 1;171(9):4504-11.PMID: 14568923 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.

    La Cava A, Balasa B, Good A, van Gunst K, Jung N, Sarvetnick N.

    J Immunol. 2001 Jul 15;167(2):1066-71.PMID: 11441117 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A critical regulatory role of leucin zipper transcription factor c-Maf in Th1-mediated experimental colitis.

    Weigmann B, Nemetz A, Becker C, Schmidt J, Strand D, Lehr HA, Galle PR, Ho IC, Neurath MF.

    J Immunol. 2004 Sep 1;173(5):3446-55.PMID: 15322210 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data